REFERENCES
1. WWF, World Wildlife Fund. Living Planet Report 2020. Bending the curve of biodiversity loss. 2020: World Wildlife Fund. Available from: https://wwf.panda.org/es/campanas_ambientales/ipv2020/ [Last accessed on 28 Apr 2023].
2. Brundtland, Report of the World Commission on environment and development:"our common future". 1987: United Nations. Available from: http://www.un-documents.net/wced-ocf.htm [Last accessed on 28 Apr 2023].
3. Daughton CG. Non-regulated water contaminants: emerging research. Environmental Impact Assessment Review 2004;24:711-32.
5. Barceló, D., M.J. López de Alda. Contaminación y calidad química del agua: el problema de los contaminantes emergentes. Available from:http://elaguapotable.com/Contaminaci%C3%B3n%20y%20calidad%20qu%C3%ADm%20del%20agua-los%20contaminantes%20emergentes.xlsx [Last accessed on 28 Apr 2023].
6. Boxall AB, Rudd MA, Brooks BW, et al. Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect 2012;120:1221-9.
7. Blair BD, Crago JP, Hedman CJ, Klaper RD. Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern. Chemosphere 2013;93:2116-23.
8. Sui Q, Cao X, Lu S, et al. Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: a review. Emerging Contaminants 2015;1:14-24.
9. aus der Beek T, Weber FA, Bergmann A, et al. Pharmaceuticals in the environment--global occurrences and perspectives. Environ Toxicol Chem 2016;35:823-35.
10. Wilkinson JL, Boxall ABA, Kolpin DW, et al. Pharmaceutical pollution of the world's rivers. Proc Natl Acad Sci USA 2022:119.
11. Puckowski A, Mioduszewska K, Łukaszewicz P, et al. Bioaccumulation and analytics of pharmaceutical residues in the environment: a review. J Pharm Biomed Anal 2016;127:232-55.
12. Huerta B, Rodriguez-Mozaz S, Lazorchak J, et al. Presence of pharmaceuticals in fish collected from urban rivers in the U.S. EPA 2008-2009 national rivers and streams assessment. Sci Total Environ 2018;634:542-9.
13. Ankley GT, Brooks BW, Huggett DB, Sumpter JP. Repeating history: pharmaceuticals in the environment. Environ Sci Technol 2007;41:8211-7.
14. Fent K, Weston AA, Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006;76:122-59.
15. Weinberger J 2nd, Klaper R. Environmental concentrations of the selective serotonin reuptake inhibitor fluoxetine impact specific behaviors involved in reproduction, feeding and predator avoidance in the fish Pimephales promelas (fathead minnow). Aquat Toxicol 2014;151:77-83.
16. Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhøft HC, Jørgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment--a review. Chemosphere 1998;36:357-93.
17. Flaherty CM, Dodson SI. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 2005;61:200-7.
18. Arnaud MJ. The pharmacology of caffeine. In: Jucker E, Meyer U, editors. Progress in drug research/fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques. Basel: Birkhäuser; 1987. pp. 273-313.
19. Vethaak AD, Lahr J, Schrap SM, et al. An integrated assessment of estrogenic contamination and biological effects in the aquatic environment of The Netherlands. Chemosphere 2005;59:511-24.
20. Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 1999;107 Suppl 6:907-38.
21. Delgado N, Capparelli A, Navarro A, Marino D. Pharmaceutical emerging pollutants removal from water using powdered activated carbon: Study of kinetics and adsorption equilibrium. J Environ Manage 2019;236:301-8.
22. Delgado N, Navarro A, Marino D, Peñuela GA, Ronco A. Removal of pharmaceuticals and personal care products from domestic wastewater using rotating biological contactors. Int J Environ Sci Technol 2019;16:1-10.
23. Delgado N, Bermeo L, Hoyos DA, et al. Occurrence and removal of pharmaceutical and personal care products using subsurface horizontal flow constructed wetlands. Water Res 2020;187:116448.
24. Delgado N, Marino D, Capparelli A, Casas-zapata JC, Navarro A. Pharmaceutical compound removal using down-flow fixed bed filters with powder activated carbon: a novel configuration. Journal of Environmental Chemical Engineering 2022;10:107706.
25. R Core Team. R: a language and environment for statistical computing. Viena; 2022. Available from: http://www.R-project.org/ Available from: http://www.R-project.org/[Last accessed on 28 Apr 2023].
28. Kahle, D.J, H. Wickham. ggmap: Spatial visualization with ggplot2. The R Journal; 2013. 5: p. 144-161. Available from: https://journal.r-project.org/archive/2013-1/kahle-wickham.xlsx [Last accessed on 28 Apr 2023].
29. Batucan NSP, Tremblay LA, Northcott GL, Matthaei CD. Medicating the environment? Environmental Advances 2022;7:100164.
30. Campanha MB, Awan AT, de Sousa DN, et al. A 3-year study on occurrence of emerging contaminants in an urban stream of São Paulo State of Southeast Brazil. Environ Sci Pollut Res Int 2015;22:7936-47.
31. Buerge II, Poiger T, Müller MD, Buser HR. Caffeine, an anthropogenic marker for wastewater comtamination of surface waters. Environ Sci Technol 2003;37:691-700.
32. Montagner CC, Jardim WF. Spatial and seasonal variations of pharmaceuticals and endocrine disruptors in the Atibaia River, São Paulo State (Brazil). J Braz Chem Soc 2011;22:1452-62.
33. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002;36:1202-11.
34. Bedoya-Ríos DF, Lara-Borrero JA, Duque-Pardo V, Madera-Parra CA, Jimenez EM, Toro AF. Study of the occurrence and ecosystem danger of selected endocrine disruptors in the urban water cycle of the city of Bogotá, Colombia. J Environ Sci Health A Tox Hazard Subst Environ Eng 2018;53:317-25.
35. Batt AL, Kincaid TM, Kostich MS, Lazorchak JM, Olsen AR. Evaluating the extent of pharmaceuticals in surface waters of the United States using a national-scale rivers and streams assessment survey. Environ Toxicol Chem 2016;35:874-81.
36. Burns EE, Thomas-Oates J, Kolpin DW, Furlong ET, Boxall ABA. Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose? Environ Toxicol Chem 2017;36:2823-32.
37. Gros M, Rodríguez-Mozaz S, Barceló D. Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J Chromatogr A 2012;1248:104-21.
38. Elorriaga Y, Marino DJ, Carriquiriborde P, Ronco AE. Human pharmaceuticals in wastewaters from urbanized areas of Argentina. Bull Environ Contam Toxicol 2013;90:397-400.
39. Valdés ME, Santos LHMLM, Rodríguez Castro MC, et al. Distribution of antibiotics in water, sediments and biofilm in an urban river (Córdoba, Argentina, LA). Environ Pollut 2021;269:116133.
40. Archundia D, Duwig C, Lehembre F, et al. Antibiotic pollution in the Katari subcatchment of the Titicaca Lake: major transformation products and occurrence of resistance genes. Sci Total Environ 2017;576:671-82.
41. Auta A, Hadi MA, Oga E, et al. Global access to antibiotics without prescription in community pharmacies: a systematic review and meta-analysis. J Infect 2019;78:8-18.
42. Enrique LE LE, Núñez Jover JR, Hernández Alfonso EA EA, et al. Pensamiento latinoamericano en ciencia, tecnología e innovación: políticas, determinantes y prácticas. Desde el Sur 2022;14:e0008.
43. Salgado Costa, C, et al. First evidence of environmental bioaccumulation of pharmaceuticals on adult native anurans (Rhinella arenarum) from Argentina. Forthcoming 2023.
44. Świacka K, Maculewicz J, Kowalska D, Caban M, Smolarz K, Świeżak J. Presence of pharmaceuticals and their metabolites in wild-living aquatic organisms - current state of knowledge. J Hazard Mater 2022;424:127350.
45. Ondarza PM, Haddad SP, Avigliano E, Miglioranza KSB, Brooks BW. Pharmaceuticals, illicit drugs and their metabolites in fish from Argentina: implications for protected areas influenced by urbanization. Sci Total Environ 2019;649:1029-37.
46. Mastrángelo MM, Valdés ME, Eissa B, et al. Occurrence and accumulation of pharmaceutical products in water and biota of urban lowland rivers. Sci Total Environ 2022;828:154303.
47. Gobas FA, de Wolf W, Burkhard LP, Verbruggen E, Plotzke K. Revisiting bioaccumulation criteria for POPs and PBT assessments. Integr Environ Assess Manag 2009;5:624-37.
48. Valdés ME, Huerta B, Wunderlin DA, Bistoni MA, Barceló D, Rodriguez-Mozaz S. Bioaccumulation and bioconcentration of carbamazepine and other pharmaceuticals in fish under field and controlled laboratory experiments. evidences of carbamazepine metabolization by fish. Sci Total Environ 2016;557-558:58-67.
49. Bean TG, Rattner BA, Lazarus RS, et al. Pharmaceuticals in water, fish and osprey nestlings in delaware river and bay. Environ Pollut 2018;232:533-45.
50. Cacua-Ortiz SM, Aguirre NJ, Peñuela GA. Methyl paraben and carbamazepine in water and striped catfish (Pseudoplatystoma magdaleniatum) in the cauca and magdalena rivers. Bull Environ Contam Toxicol 2020;105:819-26.
51. de Solla SR, Gilroy ÈA, Klinck JS, et al. Bioaccumulation of pharmaceuticals and personal care products in the unionid mussel Lasmigona costata in a river receiving wastewater effluent. Chemosphere 2016;146:486-96.
